Back

Rethinking antiviral effects for COVID-19 in clinical studies: early initiation is key to successful treatment

2020-06-03 infectious diseases Title + abstract only
View on medRxiv
Show abstract

Development of an effective antiviral drug for COVID-19 is a global health priority. Although several candidate drugs have been identified through in vitro and in vivo models, consistent and compelling evidence for effective drugs from clinical studies is limited. The lack of evidence could be in part due to heterogeneity of virus dynamics among patients and late initiation of treatment. We first quantified the heterogeneity of viral dynamics which could be a confounder in compassionate use prog...

Predicted journal destinations

1
PLOS ONE
1737 training papers
Top 56% 11.0%
2
Scientific Reports
701 training papers
Top 24% 8.4%
3
Clinical Infectious Diseases
219 training papers
Top 6% 5.6%
4
Nature Communications
483 training papers
Top 27% 3.9%
5
Frontiers in Pharmacology
27 training papers
Top 0.7% 3.9%
6
International Journal of Infectious Diseases
115 training papers
Top 4% 3.6%
7
BMC Infectious Diseases
110 training papers
Top 2% 3.6%
8
Frontiers in Medicine
99 training papers
Top 5% 2.6%
9
JAMA Network Open
125 training papers
Top 11% 1.8%
10
Vaccines
131 training papers
Top 5% 1.8%
11
Open Forum Infectious Diseases
124 training papers
Top 7% 1.8%
12
Journal of Medical Virology
95 training papers
Top 6% 1.8%
13
Infectious Diseases and Therapy
18 training papers
#1 1.8%
14
eLife
262 training papers
Top 32% 1.4%
15
Clinical Microbiology and Infection
54 training papers
Top 4% 1.4%
16
The Journal of Infectious Diseases
137 training papers
Top 10% 1.4%
17
Nature Medicine
88 training papers
Top 9% 1.3%
18
Medicine
29 training papers
Top 3% 1.3%
19
JMIR Public Health and Surveillance
45 training papers
Top 3% 1.3%
20
New England Journal of Medicine
49 training papers
Top 2% 1.3%
21
Emerging Microbes & Infections
20 training papers
Top 0.2% 1.3%
22
The American Journal of Tropical Medicine and Hygiene
50 training papers
Top 5% 1.3%
23
BMC Medicine
155 training papers
Top 22% 1.3%
24
BMJ Open
553 training papers
Top 61% 1.1%
25
Frontiers in Public Health
135 training papers
Top 27% 1.1%
26
Frontiers in Immunology
140 training papers
Top 12% 0.9%
27
Trials
24 training papers
Top 2% 0.9%
28
The Lancet Infectious Diseases
57 training papers
Top 7% 0.9%
29
eBioMedicine
82 training papers
Top 15% 0.7%
30
Viruses
79 training papers
Top 12% 0.7%